Humana Inc (HUM) Q4 2020 Earnings Call Transcript
Humana Inc (NYSE: HUM) Q4 2020 earnings call dated Feb. 03, 2021 Corporate participants: Amy K. Smith — Vice President, Investor Relations...
Health Care
AbbVie Inc. (ABBV) Q4 2020 Earnings Call Transcript
AbbVie Inc. (NYSE: ABBV) Q4 2020 earnings call dated Feb. 03, 2021. Corporate Participants: Elizabeth Shea — Vice President of Investor Relations...
Biogen, Inc. (BIIB) Q4 2020 Earnings Call Transcript
Biogen, Inc. (NASDAQ: BIIB) Q4 2020 earnings call dated Feb. 03, 2021 Corporate Participants: Mike Hencke — Director, Investor Relations Michel Vounatsos — Chief...
Boston Scientific Corp. (BSX) Q4 2020 Earnings Call Transcript
Boston Scientific Corp. (NYSE: BSX) Q4 2020 earnings call dated Feb. 03, 2021 Corporate Participants: Susie Lisa — Vice President, Investor Relations...
AbbVie (ABBV) Earnings: 4Q20 Key Numbers
AbbVie Inc. (NYSE: ABBV) reported fourth quarter 2020 earnings results today. Worldwide net revenues rose 59.2% year-over-year to $13.8 billion...
Infographic: Key financials of Biogen (BIIB) Q4 2020 earnings report
Biogen (NASDAQ: BIIB) reported fourth-quarter 2020 financial results before the opening bell on Wednesday. The biotechnology giant reported a 22%...
CorVel (CRVL) expands scope of services as focus shifts to COVID care
In the pandemic-hit healthcare market, CorVel Corporation (NASDAQ: CRVL) is facing a major uncertainty that is as unsettling as the...
Pfizer Inc. (PFE) Q4 2020 Earnings Call Transcript
Pfizer Inc. (NYSE: PFE) Q4 2020 earnings call dated Feb. 02, 2021 Corporate Participants: Charles E. Triano — Senior Vice President, Investor...
Pfizer (PFE) Q4 Earnings: Key financials and quarterly highlights
Pfizer Inc. (NYSE: PFE) reported its fourth quarter 2020 earnings results today. Revenues increased 12% year-over-year to $11.7 billion. On...
Infographic: Vertex Pharmaceuticals (VRTX) 4Q20 Earnings Results
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) reported fourth quarter 2020 earnings results today. Total revenues increased 15% year-over-year to $1.62 billion....
Where do these companies stand in the COVID-19 vaccine race?
After the struggle with the COVID-19 pandemic and its impacts clouding most of 2020, the rollout of vaccines against COVID-19...
Thermo Fisher Scientific (TMO) Earnings: 4Q20 Key Numbers
Thermo Fisher Scientific Inc. (NYSE: TMO) reported fourth-quarter 2020 earnings results today. Revenue increased 54% year-over-year to $10.55 billion. GAAP...
Johnson & Johnson’s (JNJ) single-dose vaccine is effective but lags behind rivals
Johnson & Johnson (NYSE: JNJ)Â is the latest pharma company to provide results from the trial of its COVID-19 vaccine candidate....
Cipla Limited (CIPLA) Q3 2021 Earnings Call Transcript
Cipla Limited ( NSE : CIPLA) Q3 2021 earnings call dated Jan. 29, 2021 Corporate Participants: Kumar Gaurav — Vice President, Kotak...
Novavax (NVAX) brings its share to the COVID-19 vaccine table; stock soars
Novavax Inc.’s (NASDAQ: NVAX) shares soared 50% in morning hours on Friday after the company announced that its COVID-19 vaccine...
Dr. Reddy’s Laboratories Ltd. (RDY) Q3 2021 Earnings Call Transcript
Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) Q3 2021 earnings call dated Jan. 29, 2021 Corporate Participants: Amit Agarwal — Head of Investor...
Abiomed, Inc. (ABMD) Q3 2021 Earnings Call Transcript
Abiomed, Inc. (NASDAQ: ABMD) Q3 2021 earnings call dated Jan. 28, 2021 Corporate Participants: Todd A. Trapp — Vice President and Chief...
Abbott Laboratories (ABT) Q4 2020 Earnings Call
Abbott Laboratories (NYSE: ABT) Q4 2020 earnings call dated Jan. 27, 2021. Corporate Participants: Scott Leinenweber — Vice President, Investor Relations, Licensing and...
Abbott Laboratories (ABT) Q4 2020 Earnings Call Transcript
Abbott Laboratories (NYSE: ABT) Q4 2020 earnings call dated Jan. 27, 2021. Corporate Participants: Scott Leinenweber — Vice President, Investor Relations, Licensing...
ABT Earnings: Key numbers from Abbott Laboratories Q4 financial results
Abbott (NYSE: ABT) today announced its fourth-quarter financial results for the period ended December 31, 2020. Net earnings for the...
Fate Therapeutics (FATE) looks headed for a turnaround post-COVID
Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharma company, has been drawing the market’s attention after reporting positive results from...